aluates Reports

$ 0.0

Automative

Paclitaxel API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-16P8117

Global and China Paclitaxel API Market Insights Forecast to 2027

BUY CHAPTERS

Paclitaxel API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-16P8117

Report

October 2024

Pages:122

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Phyton

ScinoPharm

Novasep

Samyang

Polymed

TAPI (Teva)

Fresenius Kabi

Huiang biopharma

Southpharma

Yunnan Hande

Hainan Yew Pharm

Jiangsu Yew Biotechnology

Paclitaxel API - Market Size

The global market for Paclitaxel API was estimated to be worth US$ 148 million in 2023 and is forecast to a readjusted size of US$ 273.2 million by 2030 with a CAGR of 9.1% during the forecast period 2024-2030

Paclitaxel API - Market

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".

The Paclitaxel Active Pharmaceutical Ingredient (API) market is primarily driven by its widespread use as a chemotherapy drug for various types of cancer treatment, such as breast, ovarian, and lung cancer. The increasing prevalence of cancer globally and the continuous research and development efforts to improve cancer therapies contribute to the growing demand for Paclitaxel API. Additionally, the rise in government initiatives and funding for cancer research and treatment further supports market growth. However, challenges like the complexity of the production process, regulatory hurdles, and the availability of alternatives pose obstacles to the market's expansion. Maintaining a balance between cost-effective production and maintaining quality standards remains a challenge for manufacturers in the Paclitaxel API market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Paclitaxel API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Paclitaxel API by region & country, by Type, and by Application.

The Paclitaxel API market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paclitaxel API.

Market Segmentation

Scope of Paclitaxel API - Market Report

Report Metric	Details
Report Name	Paclitaxel API - Market
Forecasted market size in 2030	US$ 273.2 million
CAGR	9.1%
Forecasted years	2024 - 2030
Segment by Type:	Natural Paclitaxel API Semi-synthetic Paclitaxel API
Segment by Application	Ovarian Cancer Cervical Cancer Breast Cancer Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma, Southpharma, Yunnan Hande, Hainan Yew Pharm, Jiangsu Yew Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Paclitaxel API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Paclitaxel API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Paclitaxel API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Paclitaxel API - Market size in 2030?

Ans: The Paclitaxel API - Market size in 2030 will be US$ 273.2 million.

Who are the main players in the Paclitaxel API - Market report?

Ans: The main players in the Paclitaxel API - Market are Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma, Southpharma, Yunnan Hande, Hainan Yew Pharm, Jiangsu Yew Biotechnology

What are the Application segmentation covered in the Paclitaxel API - Market report?

Ans: The Applications covered in the Paclitaxel API - Market report are Ovarian Cancer, Cervical Cancer, Breast Cancer, Other

What are the Type segmentation covered in the Paclitaxel API - Market report?

Ans: The Types covered in the Paclitaxel API - Market report are Natural Paclitaxel API, Semi-synthetic Paclitaxel API

Recommended Reports

API Market Landscape

Anticancer Drugs

Specialty APIs

1 Market Overview

1.1 Paclitaxel API Product Introduction

1.2 Global Paclitaxel API Market Size Forecast

1.2.1 Global Paclitaxel API Sales Value (2019-2030)

1.2.2 Global Paclitaxel API Sales Volume (2019-2030)

1.2.3 Global Paclitaxel API Sales Price (2019-2030)

1.3 Paclitaxel API Market Trends & Drivers

1.3.1 Paclitaxel API Industry Trends

1.3.2 Paclitaxel API Market Drivers & Opportunity

1.3.3 Paclitaxel API Market Challenges

1.3.4 Paclitaxel API Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Paclitaxel API Players Revenue Ranking (2023)

2.2 Global Paclitaxel API Revenue by Company (2019-2024)

2.3 Global Paclitaxel API Players Sales Volume Ranking (2023)

2.4 Global Paclitaxel API Sales Volume by Company Players (2019-2024)

2.5 Global Paclitaxel API Average Price by Company (2019-2024)

2.6 Key Manufacturers Paclitaxel API Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Paclitaxel API Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Paclitaxel API

2.9 Paclitaxel API Market Competitive Analysis

2.9.1 Paclitaxel API Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Paclitaxel API Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paclitaxel API as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Natural Paclitaxel API

3.1.2 Semi-synthetic Paclitaxel API

3.2 Global Paclitaxel API Sales Value by Type

3.2.1 Global Paclitaxel API Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Paclitaxel API Sales Value, by Type (2019-2030)

3.2.3 Global Paclitaxel API Sales Value, by Type (%) (2019-2030)

3.3 Global Paclitaxel API Sales Volume by Type

3.3.1 Global Paclitaxel API Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Paclitaxel API Sales Volume, by Type (2019-2030)

3.3.3 Global Paclitaxel API Sales Volume, by Type (%) (2019-2030)

3.4 Global Paclitaxel API Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Ovarian Cancer

4.1.2 Cervical Cancer

4.1.3 Breast Cancer

4.1.4 Other

4.2 Global Paclitaxel API Sales Value by Application

4.2.1 Global Paclitaxel API Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Paclitaxel API Sales Value, by Application (2019-2030)

4.2.3 Global Paclitaxel API Sales Value, by Application (%) (2019-2030)

4.3 Global Paclitaxel API Sales Volume by Application

4.3.1 Global Paclitaxel API Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Paclitaxel API Sales Volume, by Application (2019-2030)

4.3.3 Global Paclitaxel API Sales Volume, by Application (%) (2019-2030)

4.4 Global Paclitaxel API Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Paclitaxel API Sales Value by Region

5.1.1 Global Paclitaxel API Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Paclitaxel API Sales Value by Region (2019-2024)

5.1.3 Global Paclitaxel API Sales Value by Region (2025-2030)

5.1.4 Global Paclitaxel API Sales Value by Region (%), (2019-2030)

5.2 Global Paclitaxel API Sales Volume by Region

5.2.1 Global Paclitaxel API Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Paclitaxel API Sales Volume by Region (2019-2024)

5.2.3 Global Paclitaxel API Sales Volume by Region (2025-2030)

5.2.4 Global Paclitaxel API Sales Volume by Region (%), (2019-2030)

5.3 Global Paclitaxel API Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Paclitaxel API Sales Value, 2019-2030

5.4.2 North America Paclitaxel API Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Paclitaxel API Sales Value, 2019-2030

5.5.2 Europe Paclitaxel API Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Paclitaxel API Sales Value, 2019-2030

5.6.2 Asia Pacific Paclitaxel API Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Paclitaxel API Sales Value, 2019-2030

5.7.2 South America Paclitaxel API Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Paclitaxel API Sales Value, 2019-2030

5.8.2 Middle East & Africa Paclitaxel API Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Paclitaxel API Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Paclitaxel API Sales Value

6.2.1 Key Countries/Regions Paclitaxel API Sales Value, 2019-2030

6.2.2 Key Countries/Regions Paclitaxel API Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Paclitaxel API Sales Value, 2019-2030

6.3.2 United States Paclitaxel API Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Paclitaxel API Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Paclitaxel API Sales Value, 2019-2030

6.4.2 Europe Paclitaxel API Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Paclitaxel API Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Paclitaxel API Sales Value, 2019-2030

6.5.2 China Paclitaxel API Sales Value by Type (%), 2023 VS 2030

6.5.3 China Paclitaxel API Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Paclitaxel API Sales Value, 2019-2030

6.6.2 Japan Paclitaxel API Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Paclitaxel API Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Paclitaxel API Sales Value, 2019-2030

6.7.2 South Korea Paclitaxel API Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Paclitaxel API Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Paclitaxel API Sales Value, 2019-2030

6.8.2 Southeast Asia Paclitaxel API Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Paclitaxel API Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Paclitaxel API Sales Value, 2019-2030

6.9.2 India Paclitaxel API Sales Value by Type (%), 2023 VS 2030

6.9.3 India Paclitaxel API Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Phyton

7.1.1 Phyton Company Information

7.1.2 Phyton Introduction and Business Overview

7.1.3 Phyton Paclitaxel API Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Phyton Paclitaxel API Product Offerings

7.1.5 Phyton Recent Development

7.2 ScinoPharm

7.2.1 ScinoPharm Company Information

7.2.2 ScinoPharm Introduction and Business Overview

7.2.3 ScinoPharm Paclitaxel API Sales, Revenue and Gross Margin (2019-2024)

7.2.4 ScinoPharm Paclitaxel API Product Offerings

7.2.5 ScinoPharm Recent Development

7.3 Novasep

7.3.1 Novasep Company Information

7.3.2 Novasep Introduction and Business Overview

7.3.3 Novasep Paclitaxel API Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Novasep Paclitaxel API Product Offerings

7.3.5 Novasep Recent Development

7.4 Samyang

7.4.1 Samyang Company Information

7.4.2 Samyang Introduction and Business Overview

7.4.3 Samyang Paclitaxel API Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Samyang Paclitaxel API Product Offerings

7.4.5 Samyang Recent Development

7.5 Polymed

7.5.1 Polymed Company Information

7.5.2 Polymed Introduction and Business Overview

7.5.3 Polymed Paclitaxel API Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Polymed Paclitaxel API Product Offerings

7.5.5 Polymed Recent Development

7.6 TAPI (Teva)

7.6.1 TAPI (Teva) Company Information

7.6.2 TAPI (Teva) Introduction and Business Overview

7.6.3 TAPI (Teva) Paclitaxel API Sales, Revenue and Gross Margin (2019-2024)

7.6.4 TAPI (Teva) Paclitaxel API Product Offerings

7.6.5 TAPI (Teva) Recent Development

7.7 Fresenius-kabi

7.7.1 Fresenius-kabi Company Information

7.7.2 Fresenius-kabi Introduction and Business Overview

7.7.3 Fresenius-kabi Paclitaxel API Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Fresenius-kabi Paclitaxel API Product Offerings

7.7.5 Fresenius-kabi Recent Development

7.8 Huiang biopharma

7.8.1 Huiang biopharma Company Information

7.8.2 Huiang biopharma Introduction and Business Overview

7.8.3 Huiang biopharma Paclitaxel API Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Huiang biopharma Paclitaxel API Product Offerings

7.8.5 Huiang biopharma Recent Development

7.9 Southpharma

7.9.1 Southpharma Company Information

7.9.2 Southpharma Introduction and Business Overview

7.9.3 Southpharma Paclitaxel API Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Southpharma Paclitaxel API Product Offerings

7.9.5 Southpharma Recent Development

7.10 Yunnan Hande

7.10.1 Yunnan Hande Company Information

7.10.2 Yunnan Hande Introduction and Business Overview

7.10.3 Yunnan Hande Paclitaxel API Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Yunnan Hande Paclitaxel API Product Offerings

7.10.5 Yunnan Hande Recent Development

7.11 Hainan Yew Pharm

7.11.1 Hainan Yew Pharm Company Information

7.11.2 Hainan Yew Pharm Introduction and Business Overview

7.11.3 Hainan Yew Pharm Paclitaxel API Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Hainan Yew Pharm Paclitaxel API Product Offerings

7.11.5 Hainan Yew Pharm Recent Development

7.12 Jiangsu Yew Biotechnology

7.12.1 Jiangsu Yew Biotechnology Company Information

7.12.2 Jiangsu Yew Biotechnology Introduction and Business Overview

7.12.3 Jiangsu Yew Biotechnology Paclitaxel API Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Jiangsu Yew Biotechnology Paclitaxel API Product Offerings

7.12.5 Jiangsu Yew Biotechnology Recent Development

8 Industry Chain Analysis

8.1 Paclitaxel API Industrial Chain

8.2 Paclitaxel API Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Paclitaxel API Sales Model

8.5.2 Sales Channel

8.5.3 Paclitaxel API Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Phyton

ScinoPharm

Novasep

Samyang

Polymed

TAPI (Teva)

Fresenius Kabi

Huiang biopharma

Southpharma

Yunnan Hande

Hainan Yew Pharm

Jiangsu Yew Biotechnology

List of Tables

Table 1. Paclitaxel API Market Trends

Table 2. Paclitaxel API Market Drivers & Opportunity

Table 3. Paclitaxel API Market Challenges

Table 4. Paclitaxel API Market Restraints

Table 5. Global Paclitaxel API Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Paclitaxel API Revenue Market Share by Company (2019-2024)

Table 7. Global Paclitaxel API Sales Volume by Company (2019-2024) & (Kg)

Table 8. Global Paclitaxel API Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Paclitaxel API Price by Company (2019-2024) & (US$/Kg)

Table 10. Key Manufacturers Paclitaxel API Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Paclitaxel API Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Paclitaxel API

Table 13. Global Paclitaxel API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paclitaxel API as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Paclitaxel API Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Paclitaxel API Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Paclitaxel API Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Paclitaxel API Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Paclitaxel API Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Paclitaxel API Sales Volume by Type: 2019 VS 2023 VS 2030 (Kg)

Table 22. Global Paclitaxel API Sales Volume by Type (2019-2024) & (Kg)

Table 23. Global Paclitaxel API Sales Volume by Type (2025-2030) & (Kg)

Table 24. Global Paclitaxel API Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Paclitaxel API Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Paclitaxel API Price by Type (2019-2024) & (US$/Kg)

Table 27. Global Paclitaxel API Price by Type (2025-2030) & (US$/Kg)

Table 28. Global Paclitaxel API Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Paclitaxel API Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Paclitaxel API Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Paclitaxel API Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Paclitaxel API Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Paclitaxel API Sales Volume by Application: 2019 VS 2023 VS 2030 (Kg)

Table 34. Global Paclitaxel API Sales Volume by Application (2019-2024) & (Kg)

Table 35. Global Paclitaxel API Sales Volume by Application (2025-2030) & (Kg)

Table 36. Global Paclitaxel API Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Paclitaxel API Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Paclitaxel API Price by Application (2019-2024) & (US$/Kg)

Table 39. Global Paclitaxel API Price by Application (2025-2030) & (US$/Kg)

Table 40. Global Paclitaxel API Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Paclitaxel API Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Paclitaxel API Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Paclitaxel API Sales Value by Region (2019-2024) & (%)

Table 44. Global Paclitaxel API Sales Value by Region (2025-2030) & (%)

Table 45. Global Paclitaxel API Sales Volume by Region (Kg): 2019 VS 2023 VS 2030

Table 46. Global Paclitaxel API Sales Volume by Region (2019-2024) & (Kg)

Table 47. Global Paclitaxel API Sales Volume by Region (2025-2030) & (Kg)

Table 48. Global Paclitaxel API Sales Volume by Region (2019-2024) & (%)

Table 49. Global Paclitaxel API Sales Volume by Region (2025-2030) & (%)

Table 50. Global Paclitaxel API Average Price by Region (2019-2024) & (US$/Kg)

Table 51. Global Paclitaxel API Average Price by Region (2025-2030) & (US$/Kg)

Table 52. Key Countries/Regions Paclitaxel API Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Paclitaxel API Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Paclitaxel API Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Paclitaxel API Sales Volume, (2019-2024) & (Kg)

Table 56. Key Countries/Regions Paclitaxel API Sales Volume, (2025-2030) & (Kg)

Table 57. Phyton Company Information

Table 58. Phyton Introduction and Business Overview

Table 59. Phyton Paclitaxel API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)

Table 60. Phyton Paclitaxel API Product Offerings

Table 61. Phyton Recent Development

Table 62. ScinoPharm Company Information

Table 63. ScinoPharm Introduction and Business Overview

Table 64. ScinoPharm Paclitaxel API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)

Table 65. ScinoPharm Paclitaxel API Product Offerings

Table 66. ScinoPharm Recent Development

Table 67. Novasep Company Information

Table 68. Novasep Introduction and Business Overview

Table 69. Novasep Paclitaxel API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)

Table 70. Novasep Paclitaxel API Product Offerings

Table 71. Novasep Recent Development

Table 72. Samyang Company Information

Table 73. Samyang Introduction and Business Overview

Table 74. Samyang Paclitaxel API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)

Table 75. Samyang Paclitaxel API Product Offerings

Table 76. Samyang Recent Development

Table 77. Polymed Company Information

Table 78. Polymed Introduction and Business Overview

Table 79. Polymed Paclitaxel API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)

Table 80. Polymed Paclitaxel API Product Offerings

Table 81. Polymed Recent Development

Table 82. TAPI (Teva) Company Information

Table 83. TAPI (Teva) Introduction and Business Overview

Table 84. TAPI (Teva) Paclitaxel API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)

Table 85. TAPI (Teva) Paclitaxel API Product Offerings

Table 86. TAPI (Teva) Recent Development

Table 87. Fresenius-kabi Company Information

Table 88. Fresenius-kabi Introduction and Business Overview

Table 89. Fresenius-kabi Paclitaxel API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)

Table 90. Fresenius-kabi Paclitaxel API Product Offerings

Table 91. Fresenius-kabi Recent Development

Table 92. Huiang biopharma Company Information

Table 93. Huiang biopharma Introduction and Business Overview

Table 94. Huiang biopharma Paclitaxel API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)

Table 95. Huiang biopharma Paclitaxel API Product Offerings

Table 96. Huiang biopharma Recent Development

Table 97. Southpharma Company Information

Table 98. Southpharma Introduction and Business Overview

Table 99. Southpharma Paclitaxel API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)

Table 100. Southpharma Paclitaxel API Product Offerings

Table 101. Southpharma Recent Development

Table 102. Yunnan Hande Company Information

Table 103. Yunnan Hande Introduction and Business Overview

Table 104. Yunnan Hande Paclitaxel API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)

Table 105. Yunnan Hande Paclitaxel API Product Offerings

Table 106. Yunnan Hande Recent Development

Table 107. Hainan Yew Pharm Company Information

Table 108. Hainan Yew Pharm Introduction and Business Overview

Table 109. Hainan Yew Pharm Paclitaxel API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)

Table 110. Hainan Yew Pharm Paclitaxel API Product Offerings

Table 111. Hainan Yew Pharm Recent Development

Table 112. Jiangsu Yew Biotechnology Company Information

Table 113. Jiangsu Yew Biotechnology Introduction and Business Overview

Table 114. Jiangsu Yew Biotechnology Paclitaxel API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)

Table 115. Jiangsu Yew Biotechnology Paclitaxel API Product Offerings

Table 116. Jiangsu Yew Biotechnology Recent Development

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Paclitaxel API Downstream Customers

Table 120. Paclitaxel API Distributors List

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Paclitaxel API Product Picture

Figure 2. Global Paclitaxel API Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Paclitaxel API Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Paclitaxel API Sales Volume (2019-2030) & (Kg)

Figure 5. Global Paclitaxel API Sales Price (2019-2030) & (US$/Kg)

Figure 6. Paclitaxel API Report Years Considered

Figure 7. Global Paclitaxel API Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Paclitaxel API Players Sales Volume Ranking (2023) & (Kg)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Paclitaxel API Revenue in 2023

Figure 10. Paclitaxel API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Natural Paclitaxel API Picture

Figure 12. Semi-synthetic Paclitaxel API Picture

Figure 13. Global Paclitaxel API Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Paclitaxel API Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Paclitaxel API Sales Volume by Type (2019 VS 2023 VS 2030) & (Kg)

Figure 16. Global Paclitaxel API Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Paclitaxel API Price by Type (2019-2030) & (US$/Kg)

Figure 18. Product Picture of Ovarian Cancer

Figure 19. Product Picture of Cervical Cancer

Figure 20. Product Picture of Breast Cancer

Figure 21. Product Picture of Other

Figure 22. Global Paclitaxel API Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Paclitaxel API Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global Paclitaxel API Sales Volume by Application (2019 VS 2023 VS 2030) & (Kg)

Figure 25. Global Paclitaxel API Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global Paclitaxel API Price by Application (2019-2030) & (US$/Kg)

Figure 27. North America Paclitaxel API Sales Value (2019-2030) & (US$ Million)

Figure 28. North America Paclitaxel API Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe Paclitaxel API Sales Value (2019-2030) & (US$ Million)

Figure 30. Europe Paclitaxel API Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific Paclitaxel API Sales Value (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Paclitaxel API Sales Value by Country (%), 2023 VS 2030

Figure 33. South America Paclitaxel API Sales Value (2019-2030) & (US$ Million)

Figure 34. South America Paclitaxel API Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa Paclitaxel API Sales Value (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa Paclitaxel API Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions Paclitaxel API Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions Paclitaxel API Sales Volume (%), (2019-2030)

Figure 39. United States Paclitaxel API Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States Paclitaxel API Sales Value by Type (%), 2023 VS 2030

Figure 41. United States Paclitaxel API Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe Paclitaxel API Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe Paclitaxel API Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe Paclitaxel API Sales Value by Application (%), 2023 VS 2030

Figure 45. China Paclitaxel API Sales Value, (2019-2030) & (US$ Million)

Figure 46. China Paclitaxel API Sales Value by Type (%), 2023 VS 2030

Figure 47. China Paclitaxel API Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan Paclitaxel API Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan Paclitaxel API Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan Paclitaxel API Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea Paclitaxel API Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea Paclitaxel API Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea Paclitaxel API Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia Paclitaxel API Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia Paclitaxel API Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia Paclitaxel API Sales Value by Application (%), 2023 VS 2030

Figure 57. India Paclitaxel API Sales Value, (2019-2030) & (US$ Million)

Figure 58. India Paclitaxel API Sales Value by Type (%), 2023 VS 2030

Figure 59. India Paclitaxel API Sales Value by Application (%), 2023 VS 2030

Figure 60. Paclitaxel API Industrial Chain

Figure 61. Paclitaxel API Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Paclitaxel Market Insights Forecast to 2030

Global Taxol Market Research Report 2024

Global Paclitaxel and Docetaxel APIs Market Research Report 2024

Global Natural Paclitaxel Market Research Report 2024

Cabazitaxel API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Camptothecin Market Insights Forecast to 2030

Global Taxane Antineoplastic Drug Market Research Report 2024

Global Protein Bound Paclitaxel Market Research Report 2024

Global Paclitaxel Coated Balloon Catheter Market Research Report 2024

Liposomal Paclitaxel Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Protein bound Paclitaxel Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Research Report 2024

Global Paclitaxel eluting Stent Market Insights Forecast to 2030

Global Mitotic Inhibitors Market Research Report 2024

Global Bulk Paclitaxel Market Research Report 2025

Global Paclitaxel and Docetaxel Market Research Report 2024

Global Paclitaxel Micelles Market Research Report 2024

Global Albumin bound Paclitaxel Market Research Report 2024

Global Paclitaxel Polymeric Micelle Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions